173
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Dissolving microneedles: Safety Considerations and Future Perspectives

, &
Pages 283-285 | Received 18 Feb 2016, Accepted 09 Mar 2016, Published online: 14 Apr 2016

References

  • Gerstel MS Place VA . Drug Delivery Device. US patent US3964482 (1976).
  • Henry S McAllister DV Allen MG Prausnitz MR . Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci.87 (8), 922–925 (1998).
  • Tuan-Mahmood T-M McCrudden MTC Torrisi BM et al. Microneedles for intradermal and transdermal drug delivery. Eur. J. Pharm. Sci.44 (5), 623–37 (2013).
  • Garland MJ Caffarel-Salvador E Migalska K Woolfson AD Donnelly RF . Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J. Control. Rel.159 (1), 52–59 (2012).
  • Press release . Corium announces positive topline results from Phase 2a study of transdermal MicroCor(R) PTH in post-menopausal women. Corium International, Inc.http://ir.coriumgroup.com/releasedetail.cfm?releaseid=924281.
  • Hirobe S Azukizawa H Hanafusa T et al. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials57, 50–58 (2015).
  • McCrudden MTC Alkilani AZ Courtenay AJ et al. Considerations in the sterile manufacture of polymeric microneedle arrays. Drug Deliv. Transl. Res.5 (1), 3–14 (2014).
  • Donnelly RF Thakur RRS Alkilani AZ et al. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety. Int. J. Pharm.451 (1), 76–91 (2013).
  • Donnelly RF Thakur RRS Tunney MM et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm. Res.26 (11), 2513–2522 (2009).
  • Li W-Z Huo M-R Zhou J-P et al. Super-short solid silicon microneedles for transdermal drug delivery applications. Int. J. Pharm.389 (1), 122–129 (2010).
  • Markovsky E Baabur-Cohen H Eldar-Boock A et al. Administration, distribution, metabolism and elimination of polymer therapeutics. J. Control. Rel.161 (2), 446–460 (2012).
  • Nair B . Final report on the safety assessment of polyvinylpyrrolidone (PVP). Int. J. Toxicol.17 (4), 95–130 (1998).
  • Indermun S Luttge R Choonara YE et al. Current advances in the fabrication of microneedles for transdermal delivery. J. Control. Rel.185, 130–138 (2014).
  • Wang Q Yao G Dong P et al. Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution. Eur. J. Pharm. Sci.66, 148–156 (2015).
  • Lutton REM Moore J Larrañeta E Ligett S Woolfson AD Donnelly RF . Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv. Transl. Res.5 (4), 313–331 (2015).
  • Park J-H Allen MG Prausnitz MR . Polymer microneedles for controlled-release drug delivery. Pharm. Res.23 (5), 1008–1019 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.